ourselves for our patients
Founded in 1973, HanAll Biopharma has been at the forefront of scientific innovation, consistently striving to evolve and adapt for the benefit of patients. A significant milestone was achieved in 1974 when HanAll proudly introduced the first antibiotic in Korea. Since then, our company has actively engaged in collaborations with diverse multinational companies, working together to provide patients with high-value medicines.
In 2007, HanAll embarked on a new venture into the field of biopharmaceuticals. By establishing research and development centers in the United States, we successfully positioned ourselves to enter the global market. This strategic move underscored our commitment to expanding our reach and contributing to the global healthcare landscape. Subsequently Hanall extended our presence to include Japan and Indonesia.
HanAll's unwavering dedication to improving patient outcomes remains steadfast. We relentlessly explore uncharted territories in the pursuit of treatment options for individuals afflicted by rare and intractable diseases.
At HanAll, our mission as a global biopharmaceutical company is to transform the healthcare industry by pioneering cutting-edge therapies, aiming to enhance the well-being of patients and forging a more promising future.
HanAll's dedication and drive stem from our commitment to enhancing patients' lives by taking calculated risks, learning from past mistakes, and embracing challenges. We prioritize transparency, honesty, camaraderie, and generosity, while relentlessly striving to generate value for patients, caregivers, and the medical community.
At HanAll, patient input is integrated into every phase of our pipeline development. Our progress begins by identifying and assessing significant unmet medical needs. We actively seek and incorporate the experiences of patients and physicians, unearthing untapped medical insights and comprehending the impact of the target disease on patients' daily lives. These findings are subsequently incorporated into our clinical research and medical strategies.
-
Respect
-
Empathy & Diversity
-
Innovation
-
Passion